News
DNAV will demonstrate the new Sierra Automated Systems Transmission Router at this year’s NAB Show. Visitors to the Orban ...
New Jersey-headquartered technical systems consultant, systems integrator and broadcast equipment manufacturer's ...
Hosted on MSN29d
Lungpacer Medical Secures FDA Approval for AHRF TrialThe STARI trial, a Phase 2 feasibility study, will evaluate the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients suffering from AHRF.
The STARI trial (NCT06832306), a Phase 2 feasibility study, will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients ...
The STARI trial (NCT06832306), a Phase 2 feasibility study, will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback